abstract |
The invention relates to cannabinoid compositions which include delta-8-tetrahydrocannabinol (delta-8-THC), cannabidiol (CBD), delta-9-THG, natural products that reduce catabolism of delta-8-THC, delta- 8-THC, 11-hydroxy-delta-8-THC, or 11-hydroxy-delta-9-THC, as well as pharmaceutically acceptable synergistic or additive combinations of delta-8-THC and delta-9-THC. |